Camurus AB (publ) (CAMX.ST)

SEK 501.5

(-7.39%)

Eps Summary of Camurus AB (publ)

  • Camurus AB (publ)'s latest annual eps in 2023 was 7.78 SEK , up 670.3% from previous year.
  • Camurus AB (publ)'s latest quarterly eps in 2024 Q2 was 1.28 SEK , down -5.88% from previous quarter.
  • Camurus AB (publ) reported an annual eps of 1.01 SEK in 2022, up 160.84% from previous year.
  • Camurus AB (publ) reported an annual eps of -1.66 SEK in 2021, up 47.8% from previous year.
  • Camurus AB (publ) reported a quarterly eps of 1.28 SEK for 2024 Q2, down -5.88% from previous quarter.
  • Camurus AB (publ) reported a quarterly eps of 1.56 SEK for 2023 Q3, down -71.32% from previous quarter.

Annual Eps Chart of Camurus AB (publ) (2023 - 2012)

Historical Annual Eps of Camurus AB (publ) (2023 - 2012)

Year Eps Eps Growth
2023 7.78 SEK 670.3%
2022 1.01 SEK 160.84%
2021 -1.66 SEK 47.8%
2020 -3.18 SEK 48.96%
2019 -6.23 SEK -7.97%
2018 -5.77 SEK -23.29%
2017 -4.68 SEK -135.18%
2016 -1.99 SEK 63.88%
2015 -5.51 SEK -566.95%
2014 1.18 SEK -51.44%
2013 2.43 SEK 636.36%
2012 0.33 SEK 0.0%

Peer Eps Comparison of Camurus AB (publ)

Name Eps Eps Difference
Simris Alg AB (publ) -0.16 SEK 4962.5%
Vicore Pharma Holding AB (publ) -3.22 SEK 341.615%
Xbrane Biopharma AB (publ) -1.27 SEK 712.598%
Xintela AB (publ) -0.13 SEK 6084.615%
Active Biotech AB (publ) -0.17 SEK 4676.471%
Amniotics AB (publ) -0.01 SEK 70827.273%
Asarina Pharma AB (publ) -0.57 SEK 1464.912%
BioArctic AB (publ) 2.60 SEK -199.231%
Calliditas Therapeutics AB (publ) -8.69 SEK 189.528%
Cantargia AB (publ) -1.65 SEK 571.515%
Scandinavian ChemoTech AB (publ) -1.13 SEK 788.496%
CombiGene AB (publ) -1.80 SEK 532.222%
Diamyd Medical AB (publ) -1.60 SEK 586.25%
Elicera Therapeutics AB (publ) -0.83 SEK 1037.349%
Genovis AB (publ.) 0.94 SEK -727.66%
Guard Therapeutics International AB (publ) -11.26 SEK 169.094%
Mendus AB (publ) -4.40 SEK 276.818%
Isofol Medical AB (publ) -0.23 SEK 3482.609%
Intervacc AB (publ) -1.69 SEK 560.355%
Kancera AB (publ) -0.80 SEK 1072.5%
Karolinska Development AB (publ) 0.02 SEK -38800.0%
LIDDS AB (publ) -0.63 SEK 1334.921%
Lipum AB (publ) -4.45 SEK 274.831%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 4194.737%
Magle Chemoswed Holding AB (publ) 1.13 SEK -588.496%
NextCell Pharma AB -1.03 SEK 855.34%
OncoZenge AB (publ) -1.36 SEK 672.059%
Saniona AB (publ) -1.29 SEK 703.101%
Xspray Pharma AB (publ) -6.76 SEK 215.089%
Ziccum AB (publ) -1.54 SEK 605.195%
Modus Therapeutics Holding AB (publ) -1.01 SEK 870.297%
Alligator Bioscience AB (publ) -0.55 SEK 1514.545%
Sprint Bioscience AB (publ) -0.01 SEK 123592.063%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 3636.364%
Corline Biomedical AB -0.08 SEK 9339.905%
IRLAB Therapeutics AB (publ) -3.43 SEK 326.822%
Bio-Works Technologies AB (publ) -1.57 SEK 595.541%
Aptahem AB (publ) -0.05 SEK 16207.66%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 178.191%
Fluicell AB (publ) -0.24 SEK 3341.667%
Biovica International AB (publ) -2.14 SEK 463.551%
Spago Nanomedical AB (publ) -0.43 SEK 1909.302%
AcouSort AB (publ) -1.29 SEK 703.101%
Abliva AB (publ) -0.09 SEK 8706.195%
Egetis Therapeutics AB (publ) -1.27 SEK 712.598%
2cureX AB (publ) -1.85 SEK 520.541%
I-Tech AB 1.70 SEK -357.647%
Hansa Biopharma AB (publ) -15.83 SEK 149.147%
Cyxone AB (publ) -0.22 SEK 3636.364%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 492.929%
Biosergen AB -0.60 SEK 1396.667%
Nanologica AB (publ) -2.05 SEK 479.512%
SynAct Pharma AB -6.64 SEK 217.169%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 3092.308%
BioInvent International AB (publ) -5.02 SEK 254.98%
Stayble Therapeutics AB (publ) -0.92 SEK 945.652%
Alzinova AB (publ) -0.41 SEK 1997.561%
Oncopeptides AB (publ) -1.96 SEK 496.939%
Pila Pharma AB (publ) -0.47 SEK 1755.319%
Ascelia Pharma AB (publ) -3.24 SEK 340.123%
Diagonal Bio AB (publ) -0.32 SEK 2531.25%